Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder Cancer

10 May 2021

Abstract excerpt

BACKGROUND: Finding effective prognostic signatures is of great urgency due to the high risk of recurrence and progression of bladder cancer (BC). Although a lot of genetic alterations are involved in the carcinogenesis, none of them were referred in the current risk group stratifications. In this study, we aimed to find significant copy number variations (CNVs) to predict prognosis for BC patients. METHODS: CNVs...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Genomic variations and chromosomal abnormalities

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34041036
DOI: 10.3389/fonc.2021.674933

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Copy Number Variations of CEP63, FOSL2 and PAQR6 Serve as Novel Signatures for the Prognosis of Bladder CancerPMID 34041036Read ↗

Integrative analysis of prognostic long non-coding RNAs with copy number variation in bladder cancerSemantic proximity Read ↗

Clinical impact of copy number variation changes in bladder cancer samplesSemantic proximity Read ↗

Copy number variation analysis of m6 A regulators identified METTL3 as a prognostic and immune-related biomarker in bladder cancer.Semantic proximity Read ↗

Identification of a nine‐gene panel as a prognostic indicator for recurrence with muscle‐invasive bladder cancerSemantic proximity Read ↗

Copy number variations in urine cell-free DNA from bladder neoplasm patientsSemantic proximity Read ↗

Urinary Exosomal and cell-free DNA Detects Somatic Mutation and Copy Number Alteration in Urothelial Carcinoma of BladderSemantic proximity Read ↗

Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder CancerSemantic proximity Read ↗

Spotlight on Differentially Expressed Genes in Urinary Bladder CancerSemantic proximity Read ↗

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancerSemantic proximity Read ↗

Integrative Analysis of 1q23.3 Copy-Number Gain in Metastatic Urothelial CarcinomaSemantic proximity Read ↗

Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer.Semantic proximity Read ↗

Multiple‐level copy number variations in cell‐free DNA for prognostic prediction of HCC with radical treatmentsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.